Holen Sie sich die Stockscreener-App
40.60
1.17%
-0.52
Schlusskurs vom Vortag:
$41.12
Offen:
$41.83
24-Stunden-Volumen:
1.48M
Relative Volume:
0.67
Marktkapitalisierung:
$8.37B
Einnahmen:
$2.09B
Nettoeinkommen (Verlust:
$424.88M
KGV:
19.86
EPS:
2.0439
Netto-Cashflow:
$447.20M
1W Leistung:
-8.78%
1M Leistung:
-19.38%
6M Leistung:
-10.25%
1J Leistung:
+4.47%
1-Tages-Spanne:
$40.61
$42.07
1-Wochen-Bereich:
$40.28
$44.02
52-Wochen-Spanne:
$38.13
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Compare QGEN vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
40.61 | 8.47B | 2.09B | 424.88M | 447.20M | 2.0439 |
|
TMO
Thermo Fisher Scientific Inc
|
465.13 | 176.79B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
186.93 | 131.71B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
572.16 | 45.48B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.51 | 31.55B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
286.00 | 27.79B | 3.17B | 642.63M | 516.49M | 10.77 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-22 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Today's Analyst Upgrade: Deutsche Bank Recommends Buy for QGEN | QGEN Stock News - GuruFocus
Korea Investment CORP Sells 93,167 Shares of Qiagen N.V. $QGEN - MarketBeat
Deutsche Bank upgrades Qiagen stock rating to buy on valuation - Investing.com
QIAGEN NV : Upgraded to Buy by Deutsche Bank - marketscreener.com
Deutsche Bank Upgrades Qiagen NV (QGEN) to Buy - StreetInsider
Assessing Qiagen (QGEN) Valuation After Recent Share Price Weakness - Yahoo Finance
BlackRock Builds Significant Stake in Qiagen with Over 11% of Voting Rights - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen (NYSE:QGEN) Downgraded by Zacks Research to Strong Sell - MarketBeat
Jefferies Financial Group Inc. Makes New Investment in Qiagen N.V. $QGEN - MarketBeat
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndro - pharmiweb.com
Why is Qiagen (QGEN) down 9.4% since last earnings report? - MSN
Natixis Advisors LLC Increases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. (NYSE:QGEN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
Qiagen N.V. $QGEN Shares Acquired by Barclays PLC - MarketBeat
Qiagen at Leerink Global Healthcare Conference: Strategic Growth and Challenges - Investing.com India
CEO Change: Is Qiagen NV exposed to political risk2025 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn
Why Is Qiagen (QGEN) Down 9.4% Since Last Earnings Report? - Yahoo Finance
Victory Capital Management Inc. Decreases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Did Qiagen’s Strategic Review Signal A Sale, Or Just A SHIFT Toward Capital Returns? - Smartkarma
Segall Bryant & Hamill LLC Lowers Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen Reports Higher Stake by Massachusetts Financial Services in Voting Rights Disclosure - The Globe and Mail
Qiagen Reports Restricted Stock Unit Grant to Supervisory Board Member - The Globe and Mail
Qiagen discloses RSU vesting and share settlement for board member Eva Pisa - The Globe and Mail
QIAGEN Updates Total Voting Rights to 206.8 Million - TipRanks
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
Qiagen N.V. (NYSE:QGEN) Sees Significant Growth in Short Interest - MarketBeat
BlackRock Lifts Stake in Qiagen to Over 10% of Capital - TipRanks
Qiagen Discloses Executive Equity Award Vesting Under Long-Term Incentive Plan - TipRanks
Qiagen Reports Grant of Restricted Stock Units to Board Member - TipRanks
Qiagen Grants Performance Stock Units to Managing Board Member - TipRanks
QIAGEN Reports Supervisory Board Member’s Restricted Stock Unit Release - TipRanks
Qiagen Discloses Manager’s Restricted Stock Unit Vesting and Share Settlement - TipRanks
QIAGEN reports executive equity award vesting under MAR disclosure rules - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - TradingView
Qiagen (QGEN) Shares Cross Below 200 DMA - Nasdaq
BlackRock Discloses 10.68% Capital Interest and 11.8% Voting Stake in Qiagen - TipRanks
Qiagen N.V. (QGEN) Presents at Morgan Stanley European Healthcare ConferenceSlideshow - Seeking Alpha
Intech Investment Management LLC Invests $3.27 Million in Qiagen N.V. $QGEN - MarketBeat
Qiagen CEO says working with advisers on strategic review (QGEN:NYSE) - Seeking Alpha
Qiagen NV (QGEN) Trading Down 3.11% on Mar 2 - GuruFocus
QIAGEN engages advisors to review strategic alternatives - StreetInsider
getLinesFromResByArray error: size == 0 How Qiagen N.V. stock performs in rate cut cyclesJuly 2025 Outlook & Safe Entry Point Identification - mfd.ru
Qiagen N.V. (QGEN) Stock Report: Potential 10.91% Upside With Strong Buy Ratings - DirectorsTalk Interviews
Zacks Research Comments on Qiagen's Q4 Earnings (NYSE:QGEN) - MarketBeat
JPMorgan Chase & Co. Sells 512,299 Shares of Qiagen N.V. $QGEN - MarketBeat
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
0.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):